BuddyPress.org

Velasof is a generic (analogue) of the Epclusa product manufactured by Gilead. They produce a generic tablet form, and its effectiveness in treating HCV is confirmed by numerous clinical trials. Each pack of Velasof contains a bottle with 28 film-coated tablets.
Generic Epclusa is a pangenotypic drug combination consisting of components that provide interferon therapy for viral hepatitis C from the first to the sixth genotypes (GT 1 – 6). The drug belongs to the group of the newest. Registered in the USA by the FDA at the end of May 2016. Epklusa is a tandem of two active ingredients: sofosbuvir and velpatasvir. This ensures effective treatment of hepatitis C caused by a virus of 1-6 strains (genotypes)